Wrist monitor tracks ICU survivors at home – could spot problems early

NCT ID NCT07466446

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a wrist-worn activity monitor can help doctors understand how people recover after leaving the intensive care unit (ICU). 40 adults who spent more than a week in the ICU will wear the device for two months at home and answer health questionnaires. The goal is to see if movement data relates to symptoms like pain, anxiety, and daily function, and whether the device is practical for home use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
wrist-worn activity monitor
What this could lead to
If successful, this could show that wearable devices help doctors monitor recovery at home and catch issues like pain or anxiety early after ICU discharge.
What could go wrong
This is a small, early feasibility study with only 40 participants and no comparison group. It may not prove that the device improves outcomes, only that data collection is possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-INTENSIVE CARE SYNDROME (PICS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Cognitive Dysfunction Critical Illness Pain postintensive care syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • St Johns Hospital

    RECRUITING

    Livingston, EH54 6PP, United Kingdom

  • The Royal Infirmary of Edinburgh

    RECRUITING

    Edinburgh, EH16 4SA, United Kingdom

  • Western General Hospital

    RECRUITING

    Edinburgh, EH4 2XU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.